Latest Period
Q1 2026
CUSIP: 878972108
Latest Period
Q1 2026
Institutions Reporting
111
Shares (Excl. Options)
13,811,456
Price
$30.91
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 111 institutions filings for Q1 2026.
Security key
878972108
Latest holder period
Q1 2026
13F holders
111
13D/G owners
5
CIK / CUSIP context first
Broader feeds
Open recent reporting periods for CUSIP 878972108:
13D/G owners
Large-stake holder rows connected to Schedule 13D/G evidence.
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| SPRINGER TIMOTHY A | 32% | +7.9% | $96,537,428 | +$1,958,250 | 4,313,558 | +2.1% | Timothy A. Springer | 03 Apr 2025 |
| FMR LLC | 15% | +47% | $62,650,568 | +$28,714,995 | 2,799,400 | +85% | FMR LLC | 31 Mar 2025 |
| TCG Crossover GP II, LLC | 6.2% | $24,202,334 | 1,169,760 | Chen Yu | 12 Feb 2026 | |||
| Aberdeen Group plc | 6.1% | $23,818,449 | 1,141,824 | Aberdeen Group plc | 31 Dec 2025 | |||
| MCGUIRE TERRANCE | 6.3% | 0% | $14,725,503 | -$11,190,022 | 657,976 | -43% | Terrance McGuire | 03 Apr 2025 |
As of 31 Mar 2026, 111 institutional investors reported holding 13,811,456 shares of Tectonic Therapeutic, Inc. - Common Stock, $0.0001 par value per share (TECX). This represents 73% of the company’s total 18,867,097 outstanding shares.
13F concentration
Largest 13F positions for this security by reported shares and value.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 15% | 2,816,494 | +0.32% | 0% | $87,057,820 |
| TCG Crossover Management, LLC | 6.4% | 1,204,891 | 1.1% | $37,243,181 | |
| Aberdeen Group plc | 6.1% | 1,141,824 | 0% | 0.06% | $35,293,780 |
| BlackRock, Inc. | 4.6% | 860,352 | +0.7% | 0% | $26,593,482 |
| BRAIDWELL LP | 4.5% | 847,151 | -8.7% | 0.87% | $26,185,437 |
| First Light Asset Management, LLC | 3.4% | 647,743 | 1.8% | $20,021,736 | |
| BAKER BROS. ADVISORS LP | 3.2% | 607,788 | -33% | 0.11% | $18,786,727 |
| 5AM Venture Management, LLC | 3.2% | 606,660 | 0% | 5.2% | $18,751,861 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.5% | 473,532 | 0% | 0% | $14,636,874 |
| Vestal Point Capital, LP | 1.7% | 328,000 | 0% | 0.28% | $10,138,480 |
| Bollard Group LLC | 1.6% | 302,953 | 0% | 0.29% | $9,364,000 |
| KENNEDY CAPITAL MANAGEMENT LLC | 1.5% | 286,682 | +37% | 0.19% | $8,861,341 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.4% | 268,273 | +1.8% | 0% | $8,294,010 |
| MARSHALL WACE, LLP | 1.2% | 229,595 | +643% | 0.01% | $7,096,781 |
| ORBIMED ADVISORS LLC | 1.2% | 226,600 | -61% | 0.16% | $7,004,206 |
| STATE STREET CORP | 1.1% | 213,505 | +2.1% | 0% | $6,599,440 |
| Squarepoint Ops LLC | 0.87% | 164,419 | -18% | 0.01% | $5,082,191 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.87% | 164,055 | 0% | $5,072,000 | |
| Ikarian Capital, LLC | 0.83% | 157,537 | 0.7% | $4,869,469 | |
| AMERIPRISE FINANCIAL INC | 0.76% | 143,432 | 0% | $4,433,482 | |
| Opaleye Management Inc. | 0.65% | 123,000 | -43% | 0.53% | $3,801,930 |
| Soleus Capital Management, L.P. | 0.64% | 121,684 | 0.15% | $3,761,252 | |
| D. E. Shaw & Co., Inc. | 0.62% | 116,120 | -3.4% | 0% | $3,589,269 |
| WELLS FARGO & COMPANY/MN | 0.6% | 112,664 | -6.4% | 0% | $3,482,444 |
| Woodline Partners LP | 0.53% | 100,000 | -50% | 0.01% | $3,091,000 |
Quarter history
Holder count, reported shares/value, and median price by quarter.
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 13,811,456 | $426,833,189 | +$10,638,500 | $30.91 | 111 |
| 2025 Q4 | 13,814,358 | $288,147,446 | +$44,832,425 | $20.86 | 105 |
| 2025 Q3 | 12,105,071 | $189,928,399 | -$10,912,119 | $15.69 | 99 |
| 2025 Q2 | 12,112,699 | $240,681,548 | +$18,199,970 | $19.87 | 82 |
| 2025 Q1 | 11,227,627 | $198,820,413 | +$3,981,198 | $17.71 | 78 |
| 2024 Q4 | 7,686,866 | $354,905,739 | +$30,548,457 | $46.17 | 70 |
| 2024 Q3 | 7,175,807 | $217,428,427 | +$53,307,772 | $30.30 | 52 |
| 2024 Q2 | 5,345,881 | $88,045,301 | +$88,041,200 | $16.47 | 39 |